Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7987567
[patent_doc_number] => 08076078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Cystic fibrosis gene mutations'
[patent_app_type] => utility
[patent_app_number] => 12/845102
[patent_app_country] => US
[patent_app_date] => 2010-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 13616
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076078.pdf
[firstpage_image] =>[orig_patent_app_number] => 12845102
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/845102 | Cystic fibrosis gene mutations | Jul 27, 2010 | Issued |
Array
(
[id] => 5970531
[patent_doc_number] => 20110151464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'URINE GENE EXPRESSION RATIOS FOR DETECTION OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/843435
[patent_app_country] => US
[patent_app_date] => 2010-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 102
[patent_figures_cnt] => 102
[patent_no_of_words] => 12909
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20110151464.pdf
[firstpage_image] =>[orig_patent_app_number] => 12843435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/843435 | Urine gene expression ratios for detection of cancer | Jul 25, 2010 | Issued |
Array
(
[id] => 6568338
[patent_doc_number] => 20100273175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA'
[patent_app_type] => utility
[patent_app_number] => 12/833466
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12691
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12833466
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/833466 | METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA | Jul 8, 2010 | Abandoned |
Array
(
[id] => 8932389
[patent_doc_number] => 08492087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Method of judging risk for onset of drug-induced granulocytopenia'
[patent_app_type] => utility
[patent_app_number] => 12/833611
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11965
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12833611
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/833611 | Method of judging risk for onset of drug-induced granulocytopenia | Jul 8, 2010 | Issued |
Array
(
[id] => 6135295
[patent_doc_number] => 20110008906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss'
[patent_app_type] => utility
[patent_app_number] => 12/833467
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29729
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008906.pdf
[firstpage_image] =>[orig_patent_app_number] => 12833467
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/833467 | Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss | Jul 8, 2010 | Abandoned |
Array
(
[id] => 6196027
[patent_doc_number] => 20110027785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'METHOD FOR DETERMINING SUSCEPTIBILITY OF INDIVIDUALS TO POLYPHENOLS'
[patent_app_type] => utility
[patent_app_number] => 12/825376
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4234
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12825376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/825376 | METHOD FOR DETERMINING SUSCEPTIBILITY OF INDIVIDUALS TO POLYPHENOLS | Jun 28, 2010 | Abandoned |
Array
(
[id] => 6346884
[patent_doc_number] => 20100330573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'OPTIMIZED OLIGONUCLEOTIDES AND METHODS OF USING SAME FOR THE DETECTION, ISOLATION, QUANTIFICATION, MONITORING AND SEQUENCING OF BORDETELLA'
[patent_app_type] => utility
[patent_app_number] => 12/823692
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20219
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12823692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/823692 | OPTIMIZED OLIGONUCLEOTIDES AND METHODS OF USING SAME FOR THE DETECTION, ISOLATION, QUANTIFICATION, MONITORING AND SEQUENCING OF BORDETELLA | Jun 24, 2010 | Abandoned |
Array
(
[id] => 8721184
[patent_doc_number] => 20130072401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'METHOD AND KIT FOR THE PROGNOSIS OF COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/698219
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11355
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698219
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698219 | Method and kit for the prognosis of colorectal cancer | Jun 3, 2010 | Issued |
Array
(
[id] => 7580950
[patent_doc_number] => 20110294833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Methods for Healthy Aging'
[patent_app_type] => utility
[patent_app_number] => 12/789021
[patent_app_country] => US
[patent_app_date] => 2010-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25494
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12789021
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/789021 | Methods for Healthy Aging | May 26, 2010 | Abandoned |
Array
(
[id] => 7809277
[patent_doc_number] => 20120060231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD AND KIT FOR EVALUATION OF PREDISPOSITION TO DEVELOPMENT OF OBESITY, ANTI-OBESITY AGENT AND METHOD FOR SCREENING THEREOF, NON-HUMAN ANIMAL, ADIPOSE TISSUE, ADIPOCYTE, METHOD FOR PRODUCTION OF TRANSGENIC MOUSE, ANTIGEN, AND ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 13/320674
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7319
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20120060231.pdf
[firstpage_image] =>[orig_patent_app_number] => 13320674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320674 | Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody | May 16, 2010 | Issued |
Array
(
[id] => 6382816
[patent_doc_number] => 20100317006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'SCA RISK STRATIFICATION BY PREDICTING PATIENT RESPONSE TO ANTI-ARRHYTHMICS'
[patent_app_type] => utility
[patent_app_number] => 12/778603
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13075
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 63
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317006.pdf
[firstpage_image] =>[orig_patent_app_number] => 12778603
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778603 | SCA RISK STRATIFICATION BY PREDICTING PATIENT RESPONSE TO ANTI-ARRHYTHMICS | May 11, 2010 | Abandoned |
Array
(
[id] => 8185174
[patent_doc_number] => 20120115140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'Molecular Diagnosis of Fragile X Syndrome Associated with FMR1 Gene'
[patent_app_type] => utility
[patent_app_number] => 13/266434
[patent_app_country] => US
[patent_app_date] => 2010-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17995
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115140.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266434
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266434 | Molecular Diagnosis of Fragile X Syndrome Associated with FMR1 Gene | Apr 27, 2010 | Abandoned |
Array
(
[id] => 6588669
[patent_doc_number] => 20100291574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity'
[patent_app_type] => utility
[patent_app_number] => 12/765914
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10209
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12765914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/765914 | Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity | Apr 22, 2010 | Abandoned |
Array
(
[id] => 7711882
[patent_doc_number] => 08093001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Detection and diagnosis of smoking related cancers'
[patent_app_type] => utility
[patent_app_number] => 12/761134
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 18095
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/093/08093001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12761134
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/761134 | Detection and diagnosis of smoking related cancers | Apr 14, 2010 | Issued |
Array
(
[id] => 6328491
[patent_doc_number] => 20100197775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING & DIAGNOSING MOOD DISORDERS, SCHIZOPHRENIA, AND NEURO-PSYCHIATRIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/760330
[patent_app_country] => US
[patent_app_date] => 2010-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13453
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12760330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/760330 | METHODS AND COMPOSITIONS FOR TREATING & DIAGNOSING MOOD DISORDERS, SCHIZOPHRENIA, AND NEURO-PSYCHIATRIC DISORDERS | Apr 13, 2010 | Abandoned |
Array
(
[id] => 7776601
[patent_doc_number] => 20120040017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS AND LOW COPPER PET DIET'
[patent_app_type] => utility
[patent_app_number] => 13/263282
[patent_app_country] => US
[patent_app_date] => 2010-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31158
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040017.pdf
[firstpage_image] =>[orig_patent_app_number] => 13263282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/263282 | GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS AND LOW COPPER PET DIET | Apr 6, 2010 | Abandoned |
Array
(
[id] => 6235330
[patent_doc_number] => 20100267034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'MARKERS FOR PRENATAL DIAGNOSIS AND MONITORING'
[patent_app_type] => utility
[patent_app_number] => 12/754450
[patent_app_country] => US
[patent_app_date] => 2010-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15093
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267034.pdf
[firstpage_image] =>[orig_patent_app_number] => 12754450
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/754450 | MARKERS FOR PRENATAL DIAGNOSIS AND MONITORING | Apr 4, 2010 | Abandoned |
Array
(
[id] => 7522911
[patent_doc_number] => 08026067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Marker for prenatal diagnosis and monitoring'
[patent_app_type] => utility
[patent_app_number] => 12/724335
[patent_app_country] => US
[patent_app_date] => 2010-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 11138
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026067.pdf
[firstpage_image] =>[orig_patent_app_number] => 12724335
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724335 | Marker for prenatal diagnosis and monitoring | Mar 14, 2010 | Issued |
Array
(
[id] => 7754852
[patent_doc_number] => 20120027870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Novel Markers for Bladder Cancer Detection'
[patent_app_type] => utility
[patent_app_number] => 13/256365
[patent_app_country] => US
[patent_app_date] => 2010-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16197
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027870.pdf
[firstpage_image] =>[orig_patent_app_number] => 13256365
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/256365 | Methylation of the GATA4 gene in urine samples as a marker for bladder cancer detection | Mar 10, 2010 | Issued |
Array
(
[id] => 6417744
[patent_doc_number] => 20100167305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Methods of Detecting Mutations Associated With Ataxia-Ocular Apraxia 2 (AOA2)'
[patent_app_type] => utility
[patent_app_number] => 12/722078
[patent_app_country] => US
[patent_app_date] => 2010-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6130
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167305.pdf
[firstpage_image] =>[orig_patent_app_number] => 12722078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722078 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Mar 10, 2010 | Issued |